Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome [Phase 3]

View source ↗

Summary

Phase 3 study evaluating deucravacitinib in adults with active Sjögren's syndrome; the trial is currently active and not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Drugs mentioned

• Deucravacitinib (deucravacitinib)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Sjögren's Syndrome | Phase 3 | Status: ACTIVE_NOT_RECRUITING